Pfizer Sees Harvard Collaboration as Spark for New Drugs

When Hal Dvorak, a Harvard scientist whose ideas helped spur the advance of targeted cancer drugs, sought a partner recently to help him develop new treatments, he only had to walk two blocks to find one.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.